Virtu Financial LLC Mustang Bio, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.32 - $8.27 $12,877 - $332,793	40,241 New	40,241 $16,000
Q2 2022 Aug 09, 2022	BUY	$0.58 - $1.13 $67,521 - $131,550	116,416 Added 724.07%	132,494 $78,000
Q1 2022 May 17, 2022	SELL	$0.73 - $1.81 $3,056 - $7,578	-4,187 Reduced 20.66%	16,078 $16,000
Q4 2021 Feb 17, 2022	BUY	$1.66 - $2.64 $33,639 - $53,499	20,265 New	20,265 $34,000
Q3 2021 Nov 12, 2021	SELL	$2.58 - $3.36 $302,373 - $393,788	-117,199 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.7 - $3.81 $131,595 - $185,695	48,739 Added 71.19%	117,199 $389,000
Q1 2021 May 19, 2021	SELL	$3.02 - $5.16 $359,851 - $614,844	-119,156 Reduced 63.51%	68,460 $227,000
Q4 2020 Feb 24, 2021	BUY	$2.66 - $4.18 $410,805 - $645,550	154,438 Added 465.48%	187,616 $710,000
Q3 2020 Dec 11, 2020	BUY	$3.01 - $3.88 $99,865 - $128,730	33,178 New	33,178 $105,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.